Role of Treg Cells and TGF-β1 in Patients with Systemic Lupus Erythematosus: A Possible Relation with Lupus Nephritis

REFERENCES

• Aoki, C. A., Borchers, A. T., Li M., Flavell, R. A., Bowlus, C. L., Ansari, A. A., Gershwin, M. E. (2005). Transforming growth factor beta (TGF-beta) and autoimmunity. Autoimmun. Rev. 4(7):450–9.
   PubMed Web of Science ®Google Scholar
• Azhar, M., Yin, M., Bommireddy, R., Duffy, J. J., Yang, J., Pawlowski, S. A., Boivin, G. P., Engle, S. J., Sanford, L. P., Grisham, C., Sing, H. R. R., Babcock, G. F., Doetschman, T. (2009). Generation of mice with a conditional allele for transforming growth factor beta 1 gene. Genesis 47(6):423–31.
   Google Scholar
• Barath, S., Soltesz, P., Kiss, E., Aleksza, M., Zeher, M., Szegedi, G., Sipka, S. (2007). The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients. Autoimmunity 40(7):521–8.
   PubMed Web of Science ®Google Scholar
• Becker-Merok, A., Eilertsen, G. O., Nossent, J. C. (2010). Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease. J. Rheumatol. 37(10):2039–45.
   PubMed Web of Science ®Google Scholar
• Bonelli, M., Savitskaya, A., von Dalwigk, K., Steiner, C. W., Aletaha, D., Smolen, J. S.Scheinecker C. (2008). Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20(7):861–8.
   Google Scholar
• De Muro, P., Faedda, R., Fresu, P., Masala, A., Cigni, A., Concas, G., Mela, M. G., Satta, A., Carcassi, A., Sanna, G. M., Cherchi, G. M. (2004). Urinary transforming growth factor-beta 1 in various types of nephropathy. Pharmacol. Res. 49(3):293–8.
   PubMed Web of Science ®Google Scholar
• Fahlen, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A., Powrie, F. (2005). T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. 201(5):737–46.
   PubMedGoogle Scholar
• Gagliardini, E., Benigni, A. (2006). Role of anti-TGF-beta antibodies in the treatment of renal injury. Cytokine Growth Factor Rev. 17(1-2):89–96.
   Google Scholar
• Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A., Rudensky, A. Y. (2007). Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445(7129):771–5.
   PubMed Web of Science ®Google Scholar
• Heinlen, L. D., McClain, M. T., Merrill, J., Akbarali, Y. W., Edgerton, C. C., Harley, J. B., James, J. A. (2007). Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum, 56(7):2344–51.
   PubMedGoogle Scholar
• Hochberg, M. C. (1997). Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40(9):1725.
   PubMed Web of Science ®Google Scholar
• Kaplan, J., Woodworth, L., Smith, K., Coco, J., Vitsky, A., McPherson, J. (2008). Therapeutic benefit of treatment with anti-thymocyte globulin and latent TGF-beta1 in the MRL/lpr lupus mouse model. Lupus 17(9):822–31.
   Google Scholar
• La Cava, A., Fang, C. J., Singh, R. P., Ebling, F., Hahn, B. H. (2005). Manipulation of immune regulation in systemic lupus erythematosus. Autoimmun Rev. 4(8):515–9.
   Google Scholar
• Lyssuk, E. Y., Torgashina A. V., Soloviev S. K., Nassonov E. L., Bykovskaia, S. N. (2007). Reduced number and function of CD4+CD25highFoxP3+ regulatory T cells in patients with systemic lupus erythematosus. Adv. Exp. Med. Biol. 601:113–9.
   PubMed Web of Science ®Google Scholar
• Maloy, K. J., Powrie, F. (2001). Regulatory T cells in the control of immune pathology. Nat. Immunol. 2(9):816–22.
   PubMed Web of Science ®Google Scholar
• Marie, J. C., Letterio, J. J., Gavin, M., Rudensky, A. Y. (2005). TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201(7):1061–7.
   PubMed Web of Science ®Google Scholar
• Murakami, K., Takemura, T., Hino, S., Yoshioka, K. (1997). Urinary transforming growth factor-beta in patients with glomerular diseases. Pediatr. Nephrol. 11(3):334–6.
   Google Scholar
• Nakamura, K., Kitani, A., Strober, W. (2001). Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194(5):629–44.
   PubMed Web of Science ®Google Scholar
• Ohtsuka, K., Gray, J. D., Stimmler, M. M., Horwitz, D. A. (1999). The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity. Lupus 8(2):90–4.
   Google Scholar
• Ruiz-Arguelles, A., Alarcon-Segovia, D., Llorente, L., Del Giudice-Knipping, J. A. (1980). Heterogeneity of the spontaneously expanded and mitogen-induced generation of suppressor cell function of T cells on B cells in systemic lupus erythematosus. Arthritis Rheum. 23(9):1004–9.
   Google Scholar
• Sakaguchi, S. (2005). Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6(4):345–52.
   PubMed Web of Science ®Google Scholar
• Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., Takahashi, T. (2001). Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182:18–32.
   PubMed Web of Science ®Google Scholar
• Sfikakis, P. P., Souliotis, V. L., Fragiadaki, K. G., Moutsopoulos, H. M., Boletis, J. N., Theofilopoulos, A. N. (2007). Increased expression of the FoxP3 functional marker of regulatory T cells following B cell depletion with rituximab in patients with lupus nephritis. Clin. Immunol. 123(1):66–73.
   PubMed Web of Science ®Google Scholar
• Suarez, A., Lopez, P., Gomez, J., Gutierrez, C. (2006). Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann. Rheum. Dis. 65(11):1512–7.
   Google Scholar
• Wan, Y. Y., Flavell, R. A. (2007). Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445(7129):766–70.
   PubMed Web of Science ®Google Scholar
• Wu, H. Y., Staines, N. A. (2004). A deficiency of CD4+CD25+ T cells permits the development of spontaneous lupus-like disease in mice, and can be reversed by induction of mucosal tolerance to histone peptide autoantigen. Lupus 13(3):192–200.
   PubMed Web of Science ®Google Scholar
• Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M., Onodera, M., Uchiyama, T., Fujii, S., Sakaguchi, S. (2004). Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int. Immunol. 16(11):1643–56.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Zhang, X., Tang, F., Zhu, L., Liu, Y. (2008). Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin. Exp. Immunol. 153(2):182–7.
   Google Scholar
• Zhang, B., Zhang, X., Tang, F. L., Zhu, L. P., Liu, Y., Lipsky, P. E. (2008). Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus. Ann. Rheum. Dis. 67(7):1037–40.
   Google Scholar
• Zheng, S. G. (2010). Transforming growth factor-beta level: indicator for severity of disease and organ damage in patients with systemic lupus erythematosus. J. Rheumatol. 37(10):1983–5.
   Google Scholar
• Zheng, S. G., Gray, J. D., Ohtsuka, K., Yamagiwa, S., Horwitz, D. A. (2002). Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J. Immunol. 169(8):4183–9.
   Google Scholar
• Zheng, S. G., Wang, J., Wang, P., Gray, J. D., Horwitz, D. A. (2007). IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J. Immunol. 178(4):2018–27.
   PubMed Web of Science ®Google Scholar